Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma
- Author
- TE Hutson, ID Davis, JPH Machiels, PL De Souza, Sylvie Rottey (UGent) , BF Hong, RJ Epstein, KL Baker, L McCann, T Crofts, L Pandite and RA Figlin
- Organization
- Keywords
- INTERFERON-ALPHA, PHASE-III TRIAL, TARGETED THERAPY, DOUBLE-BLIND, SUNITINIB, CANCER
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 125.77 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-875465
- MLA
- Hutson, TE, et al. “Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma.” JOURNAL OF CLINICAL ONCOLOGY, vol. 28, no. 3, AMER SOC CLINICAL ONCOLOGY, 2010, pp. 475–80, doi:10.1200/JCO.2008.21.6994.
- APA
- Hutson, T., Davis, I., Machiels, J., De Souza, P., Rottey, S., Hong, B., … Figlin, R. (2010). Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma. JOURNAL OF CLINICAL ONCOLOGY, 28(3), 475–480. https://doi.org/10.1200/JCO.2008.21.6994
- Chicago author-date
- Hutson, TE, ID Davis, JPH Machiels, PL De Souza, Sylvie Rottey, BF Hong, RJ Epstein, et al. 2010. “Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma.” JOURNAL OF CLINICAL ONCOLOGY 28 (3): 475–80. https://doi.org/10.1200/JCO.2008.21.6994.
- Chicago author-date (all authors)
- Hutson, TE, ID Davis, JPH Machiels, PL De Souza, Sylvie Rottey, BF Hong, RJ Epstein, KL Baker, L McCann, T Crofts, L Pandite, and RA Figlin. 2010. “Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma.” JOURNAL OF CLINICAL ONCOLOGY 28 (3): 475–480. doi:10.1200/JCO.2008.21.6994.
- Vancouver
- 1.Hutson T, Davis I, Machiels J, De Souza P, Rottey S, Hong B, et al. Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma. JOURNAL OF CLINICAL ONCOLOGY. 2010;28(3):475–80.
- IEEE
- [1]T. Hutson et al., “Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma,” JOURNAL OF CLINICAL ONCOLOGY, vol. 28, no. 3, pp. 475–480, 2010.
@article{875465, author = {{Hutson, TE and Davis, ID and Machiels, JPH and De Souza, PL and Rottey, Sylvie and Hong, BF and Epstein, RJ and Baker, KL and McCann, L and Crofts, T and Pandite, L and Figlin, RA}}, issn = {{0732-183X}}, journal = {{JOURNAL OF CLINICAL ONCOLOGY}}, keywords = {{INTERFERON-ALPHA,PHASE-III TRIAL,TARGETED THERAPY,DOUBLE-BLIND,SUNITINIB,CANCER}}, language = {{eng}}, number = {{3}}, pages = {{475--480}}, publisher = {{AMER SOC CLINICAL ONCOLOGY}}, title = {{Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma}}, url = {{http://doi.org/10.1200/JCO.2008.21.6994}}, volume = {{28}}, year = {{2010}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: